Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors
About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.
Tecentriq combination fails to improve survival in metastatic lung cancer
Tiragolumab plus atezolizumab added to chemotherapy did not extend survival outcomes as first-line therapy of locally advanced unresectable or metastatic non-squamous non-small cell lung cancer, interim results from a randomized study showed.
Log in or Sign up for Free to view tailored content for your specialty!
Lung cancer risks persist with e-cigarette use after quitting tobacco smoking
SAN DIEGO — Smokers who used electronic cigarettes after quitting had more risk for lung cancer than those who quit but did not use e-cigarettes, according to a study presented at the American Thoracic Society International Conference.
Quitting smoking after cancer diagnosis may alter prognosis, provide ‘dramatic’ benefits
Individuals with laryngeal cancer who stop smoking in the 2- to 4-week window between diagnosis and their first treatment can significantly improve their response to therapy, survival rates and quality of life.
Current e-cigarette users less likely to get screened for lung cancer
The likelihood for lung cancer screening uptake was reduced among current vs. never e-cigarette users, according to results published in JAMA Network Open.
Ohio State names new medical oncology director
Christian Rolfo, MD, PhD, MBA, will be the director of the division of medical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, as of Aug. 15.
Medical cannabis provides marginal pain relief in advanced cancer
CHICAGO — Individuals with advanced cancer who received a two-component medical cannabis oil reported improvement in cancer-related pain, results from a randomized study showed.
Adjuvant durvalumab does not extend DFS in early-stage lung cancer
Adjuvant durvalumab failed to improve outcomes compared with placebo for certain patients with early-stage lung cancer, according to the agent’s manufacturer.
‘Broader and more inclusive design’ needed for novel cancer trials
Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.
Q&A: Initiative aims to help more Maryland residents get screened for lung cancer
The risk for lung cancer has been found to be particularly high in some Maryland counties, but a recently launched initiative is making sure screening is available for all eligible state residents, according to a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read